Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2017-04-28 Interim / Quarterly Rep…
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
2017年第一季度报告
Interim / Quarterly Report Classification · 99% confidence The document is titled "2017 年第一季度报告" which translates to "2017 First Quarter Report." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and management commentary for the first quarter of 2017. The report is unaudited as stated in the text. The content includes comprehensive financial statements and analysis for a period shorter than a full fiscal year, specifically a quarter. This matches the definition of an Interim / Quarterly Report (IR). The document length is substantial (15,000 characters), and it contains actual financial data, not just an announcement or certification. Therefore, the correct classification is IR with high confidence. Q1 2017
2017-04-28 Chinese
平安证券股份有限公司关于普莱柯生物工程股份有限公司对募投项目实施方案进行调整的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from Ping An Securities regarding adjustments to the implementation plan of fundraising projects by Pulike Bioengineering Co., Ltd. It includes extensive information about the original fundraising, investment amounts, project changes, reasons for changes, new project details, market prospects, risk warnings, and approvals by independent directors, supervisors, and the sponsor institution. The document references regulatory approvals and compliance with securities issuance and listing rules. It is not a full annual or interim financial report, nor is it a brief announcement or a certification letter. It is a formal audit or verification report related to fundraising project adjustments, which fits the category of an Audit Report / Information (AR). The document length (4867 characters) and content depth support this classification rather than a simple announcement or regulatory filing. Q1 2017
2017-04-18 Chinese
关于续聘会计师事务所及其费用的公告
Audit Report / Information Classification · 90% confidence The document is an announcement regarding the reappointment of an accounting firm (立信会计师事务所) for auditing the company's financial statements for the year 2017. It discusses the audit fees and the board's approval of the appointment. The document does not contain the audit report itself, nor detailed financial statements or analysis. It is a formal announcement about the audit engagement and fees, not the audit report or annual report. Therefore, it fits best under Audit Report / Information (AR) as it relates to audit matters but is not a full annual report or financial statement filing. FY 2016
2017-04-16 Chinese
会计政策、会计估计变更及会计差错更正管理制度
Governance Information Classification · 95% confidence The document is a detailed internal policy manual regarding accounting policies, accounting estimate changes, and correction of accounting errors. It references relevant laws, regulations, and standards applicable to accounting and financial reporting, including the Securities Law, Shanghai Stock Exchange rules, and accounting standards. The content focuses on governance and procedural rules for accounting changes and disclosures, including approval processes and disclosure requirements. It does not contain financial statements, earnings data, or audit results. It is not an announcement or a brief notice but a comprehensive governance document outlining internal rules and procedures related to accounting policies. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2017-04-16 Chinese
独立董事候选人声明（邹欣）
Board/Management Information Classification · 95% confidence The document is a declaration statement by an independent director candidate confirming qualifications and independence criteria. It is a formal statement related to board membership but does not announce a change in board composition or senior management. It is not a report, financial statement, or regulatory filing about financial results or corporate actions. It is a candidate declaration for an independent director position, which fits best under Board/Management Information (MANG) as it relates to board membership qualifications and disclosures.
2017-04-16 Chinese
募集资金年度存放与使用情况鉴证报告
Regulatory Filings
2017-04-16 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.